144 related articles for article (PubMed ID: 9827716)
1. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis.
Worobec AS; Semere T; Nagata H; Metcalfe DD
Cancer; 1998 Nov; 83(10):2120-9. PubMed ID: 9827716
[TBL] [Abstract][Full Text] [Related]
2. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
[TBL] [Abstract][Full Text] [Related]
4. c-kit mutation in a population of patients with mastocytosis.
Nagata H; Okada T; Worobec AS; Semere T; Metcalfe DD
Int Arch Allergy Immunol; 1997; 113(1-3):184-6. PubMed ID: 9130517
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.
Worobec AS; Akin C; Scott LM; Metcalfe DD
J Allergy Clin Immunol; 1998 Sep; 102(3):523-4. PubMed ID: 9768597
[No Abstract] [Full Text] [Related]
6. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
[TBL] [Abstract][Full Text] [Related]
7. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.
Yavuz AS; Lipsky PE; Yavuz S; Metcalfe DD; Akin C
Blood; 2002 Jul; 100(2):661-5. PubMed ID: 12091362
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of the proto-oncogene c-kit in patients with mastocytosis.
Nagata H; Worobec AS; Semere T; Metcalfe DD
Leukemia; 1998 Feb; 12(2):175-81. PubMed ID: 9519779
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
Chan IJ; Tharp MD
Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis.
Dror Y; Leaker M; Caruana G; Bernstein A; Freedman MH
Br J Haematol; 2000 Mar; 108(4):729-36. PubMed ID: 10792276
[TBL] [Abstract][Full Text] [Related]
13. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
Yanagihori H; Oyama N; Nakamura K; Kaneko F
J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
[TBL] [Abstract][Full Text] [Related]
14. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.
Longley BJ; Metcalfe DD; Tharp M; Wang X; Tyrrell L; Lu SZ; Heitjan D; Ma Y
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1609-14. PubMed ID: 9990072
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular genetic abnormalities in systemic mastocytosis.
Gupta R; Bain BJ; Knight CL
Acta Haematol; 2002; 107(2):123-8. PubMed ID: 11919394
[TBL] [Abstract][Full Text] [Related]
16. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.
Kristensen T; Vestergaard H; Bindslev-Jensen C; Møller MB; Broesby-Olsen S;
Am J Hematol; 2014 May; 89(5):493-8. PubMed ID: 24443360
[TBL] [Abstract][Full Text] [Related]
17. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
18. Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis.
Lawley W; Hird H; Mallinder P; McKenna S; Hargadon B; Murray A; Bradding P
Mutat Res; 2005 May; 572(1-2):1-13. PubMed ID: 15790486
[TBL] [Abstract][Full Text] [Related]
19. Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis.
Afonja O; Amorosi E; Ashman L; Takeshita K
Ann Hematol; 1998 Oct; 77(4):183-6. PubMed ID: 9829852
[TBL] [Abstract][Full Text] [Related]
20. Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.
Pullarkat VA; Pullarkat ST; Calverley DC; Brynes RK
Am J Hematol; 2000 Dec; 65(4):307-9. PubMed ID: 11074560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
